Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan H Lazarus

Showing results (31-40 of 77) with videos related to

Pageof 8
Sort By:
Transfusion|June 21, 2013
Antibody specific for the glycophorin A complex mediates intravenous immune globulin-resistant anemia in a murine modelXi Chen, Hasan Ghaffar, Chao-Ching Jen, et al.
Blood|December 31, 2002
Monoclonal IgG can ameliorate immune thrombocytopenia in a murine model of ITP: an alternative to IVIGSeng Song, Andrew R Crow, John Freedman, et al.
Blood Reviews|April 8, 2026
The humoral pathophysiology of immune thrombocytopenia: How close are we to patient-specific disease treatment?Peter A A Norris, Kevin D Won, Alan H Lazarus
Transfusion|March 11, 2015
A monoclonal antibody with anti-D-like activity in murine immune thrombocytopenia requires Fc domain function for immune thrombocytopenia ameliorative effectsXiaojie Yu, Melissa Menard, Gemma Seabright, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 19, 2015
IgG-Mediated Immune Suppression to Erythrocytes by Polyclonal Antibodies Can Occur in the Absence of Activating or Inhibitory Fcγ Receptors in a Full Mouse ModelLidice Bernardo, Honghui Yu, Alaa Amash, et al.
Blood|October 14, 2004
Monoclonal antibodies that mimic the action of anti-D in the amelioration of murine ITP act by a mechanism distinct from that of IVIgSeng Song, Andrew R Crow, Vinayakumar Siragam, et al.
Blood|September 7, 2006
A role for IL-1 receptor antagonist or other cytokines in the acute therapeutic effects of IVIg?Andrew R Crow, Seng Song, John W Semple, et al.
Blood|February 1, 2003
IVIG induces dose-dependent amelioration of ITP in rodent modelsAndrew R Crow, Seng Song, John W Semple, et al.
British Journal of Haematology|September 28, 2007
IgG-mediated immunosuppression is not dependent on erythrocyte clearance or immunological evasion: implications for the mechanism of action of anti-D in the prevention of haemolytic disease of the newborn?Davor Brinc, Hoang Le-Tien, Andrew R Crow, et al.
Blood|December 20, 2008
Of mice and men: an open-label pilot study for treatment of immune thrombocytopenic purpura by an inhibitor of SykAnna Podolanczuk, Alan H Lazarus, Andrew R Crow, et al.
Pageof 8

Showing results (31-40 of 77) with videos related to

Sort By:
Pageof 8
Transfusion|June 21, 2013
Antibody specific for the glycophorin A complex mediates intravenous immune globulin-resistant anemia in a murine modelXi Chen, Hasan Ghaffar, Chao-Ching Jen, et al.
Blood|December 31, 2002
Monoclonal IgG can ameliorate immune thrombocytopenia in a murine model of ITP: an alternative to IVIGSeng Song, Andrew R Crow, John Freedman, et al.
Blood Reviews|April 8, 2026
The humoral pathophysiology of immune thrombocytopenia: How close are we to patient-specific disease treatment?Peter A A Norris, Kevin D Won, Alan H Lazarus
Transfusion|March 11, 2015
A monoclonal antibody with anti-D-like activity in murine immune thrombocytopenia requires Fc domain function for immune thrombocytopenia ameliorative effectsXiaojie Yu, Melissa Menard, Gemma Seabright, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 19, 2015
IgG-Mediated Immune Suppression to Erythrocytes by Polyclonal Antibodies Can Occur in the Absence of Activating or Inhibitory Fcγ Receptors in a Full Mouse ModelLidice Bernardo, Honghui Yu, Alaa Amash, et al.
Blood|October 14, 2004
Monoclonal antibodies that mimic the action of anti-D in the amelioration of murine ITP act by a mechanism distinct from that of IVIgSeng Song, Andrew R Crow, Vinayakumar Siragam, et al.
Blood|September 7, 2006
A role for IL-1 receptor antagonist or other cytokines in the acute therapeutic effects of IVIg?Andrew R Crow, Seng Song, John W Semple, et al.
Blood|February 1, 2003
IVIG induces dose-dependent amelioration of ITP in rodent modelsAndrew R Crow, Seng Song, John W Semple, et al.
British Journal of Haematology|September 28, 2007
IgG-mediated immunosuppression is not dependent on erythrocyte clearance or immunological evasion: implications for the mechanism of action of anti-D in the prevention of haemolytic disease of the newborn?Davor Brinc, Hoang Le-Tien, Andrew R Crow, et al.
Blood|December 20, 2008
Of mice and men: an open-label pilot study for treatment of immune thrombocytopenic purpura by an inhibitor of SykAnna Podolanczuk, Alan H Lazarus, Andrew R Crow, et al.
Pageof 8